Establishment and evaluation of glucose-modified nanocomposite liposomes for the treatment of cerebral malaria

Cerebral malaria (CM) is a life-threatening neurological complication caused by Plasmodium falciparum. About 627,000 patients died of malaria in 2020. Currently, artemisinin and its derivatives are the front-line drugs used for the treatment of cerebral malaria. However, they cannot target the brain...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Ya, Zheng, Zhongyuan, Wang, Xi, Liu, Shuzhi, Gu, Liwei, Mu, Jing, Zheng, Xiaojun, Li, Yujie, Shen, Shuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258070/
https://www.ncbi.nlm.nih.gov/pubmed/35794597
http://dx.doi.org/10.1186/s12951-022-01493-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258070/
https://www.ncbi.nlm.nih.gov/pubmed/35794597
http://dx.doi.org/10.1186/s12951-022-01493-8

Ejemplares similares